Nuclear medicine in the management of patients with heart failure : guidance from an expert panel of the International Atomic Energy Agency (IAEA)
Peix, Amalia (Instituto de Cardiología y Cirugía Cardiovascular, Havana, Cuba)
Mesquita, Claudio Tinoco (Hospital Universitário Antonio Pedro, Universidade Federal Fluminense (UFF), Niteroi)
Paez, Diana (Department of Nuclear Sciences and Applications, Division of Human Health, Section of Nuclear Medicine and Diagnostic Imaging, International Atomic Energy Agency, Vienna, Austria)
Pereira, Carlos Cunha (Quanta Diagnostico Nuclear, Curitiba)
Felix, Renata (Instituto Nacional de Cardiologia, Rio de Janeiro)
Gutierrez, Claudia (Fundación Cardioinfantil, Instituto de Cardiología, Bogotá)
Jaimovich, Rodrigo (Pontificia Universidad Católica de Chile)
Ianni, Barbara Maria (Instituto do Coração, Universidade de São Paulo, São Paulo, Brazil)
Soares, Jose (Instituto do Coração, Universidade de São Paulo, São Paulo, Brazil)
Olaya, Pastor (Fundación Clínica Valle Del Lili, Cali, Colombia)
Rodriguez, Ma. Victoria (Hospital General de Coro, Coro, Venezuela)
Flotats, Albert (Institut d'Investigació Biomèdica Sant Pau)
Giubbini, Raffaele (Cattedra e U.O. di Medicina Nucleare, Università e Spedali Civili, Brescia, Italy)
Travin, Mark (Montefiore Medical Center, Yeshiva University, New York, New York)
Garcia, Ernest V. (Department of Radiology, Emory University Hospital, Emory University School of Medicine, Atlanta, Georgia, USA)
Universitat Autònoma de Barcelona

Data:	2014
Resum:	Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, 123 I-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Coronary artery disease ; Dilated cardiomyopathy ; Gated myocardial perfusion SPECT ; Left ventricular dyssynchrony ; MIBG ; PET imaging ; Heart failure
Publicat a:	Nuclear Medicine Communications, Vol. 35 (july 2014) , p. 818-823, ISSN 1473-5628

DOI: 10.1097/MNM.0000000000000143
PMID: 24781009

6 p, 339.5 KB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats